You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Afinitor

Showing 1 - 25 of 205
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pharmacokinetics Trial in Seoul (SVG101 (T), Afinitor (R))

Completed
  • Pharmacokinetics
  • SVG101 (T)
  • Afinitor (R)
  • Seoul, Korea, Republic of
    Yonsei University Healthcare System, Severance Hospital
Aug 3, 2022

Uterine Sarcoma Trial (Everolimus)

Available
  • Uterine Sarcoma
  • (no location specified)
Aug 25, 2022

Advanced Hormone Receptor Positive (HR+) Breast Cancer Trial (everolimus)

No longer available
  • Advanced Hormone Receptor Positive (HR+) Breast Cancer
  • (no location specified)
Nov 26, 2021

Breast Cancer Trial in Birmingham (Letrozole, Everolimus, TRC105)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 13, 2022

Gastrointestinal Stromal Tumor Trial (Everolimus)

Temporarily not available
  • Gastrointestinal Stromal Tumor
  • (no location specified)
May 5, 2022

Advanced Cancers, Solid Tumors Trial in Houston (Pazopanib, Everolimus)

Active, not recruiting
  • Advanced Cancers
  • Solid Tumors
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022

Epilepsy Trial in Shenyang (Everolimus, Placebo)

Recruiting
  • Epilepsy
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Nov 5, 2022

Classical Hodgkin Lymphoma Trial in Philadelphia (Itacitinib, Everolimus)

Active, not recruiting
  • Classical Hodgkin Lymphoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 28, 2022

Breast Cancer, Advanced Breast Cancer Trial in Shanghai (Everolimus 10 mg, CDK4/6 Inhibitor SHR6390, Aromatase inhibitor and

Not yet recruiting
  • Breast Cancer
  • Advanced Breast Cancer
  • Everolimus 10 mg
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 14, 2023

Liver Transplant Trial in Boston (biological, procedure, drug)

Recruiting
  • Liver Transplant
  • arTreg-CSB
  • +4 more
  • Boston, Massachusetts
    Massachusetts General Hospital: Transplantation
Jan 30, 2023

Thymoma and Thymic Carcinoma Trial in Rozzano (Everolimus)

Completed
  • Thymoma and Thymic Carcinoma
  • Rozzano, MI, Italy
    Istituto Clinico Humanitas
Sep 8, 2022

Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Advanced Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Endometrial Cancer Trial in Morristown, Houston (Letrozole, RAD001 (Everolimus))

Active, not recruiting
Has Results
  • Endometrial Cancer
  • Morristown, New Jersey
  • +1 more
Nov 16, 2022

Renal Angiomyolipoma Trial in China (Everolimus)

Completed
Has Results
  • Renal Angiomyolipoma
  • Wuhan, Hubei, China
  • +4 more
Sep 3, 2021

Breast Cancer, Metastatic Breast Cancer Trial (Elacestrant, Alpelisib, Everolimus)

Not yet recruiting
  • Breast Cancer
  • Metastatic Breast Cancer
  • (no location specified)
Sep 28, 2022

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

Liver Transplant Trial in San Francisco (biological, procedure, drug)

Recruiting
  • Liver Transplant
  • arTreg
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Sep 13, 2022

Renal Cell Carcinoma Trial in Iowa City (Lenvatinib, Everolimus, Partial or Radical Cytoreductive Nephrectomy)

Recruiting
  • Renal Cell Carcinoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
May 4, 2022

Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Everolimus, Laboratory

Recruiting
  • Advanced Malignant Neoplasm
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Epilepsy and Focal Cortical Dysplasia II Trial in Seoul (Afinitor (everolimus))

Completed
  • Epilepsy and Focal Cortical Dysplasia II
  • Afinitor (everolimus)
  • Seoul, Korea, Republic of
    Yonsei University Healthcare System, Severance Hospital
Apr 15, 2021

Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

Recruiting
  • Advanced Carcinoid Tumor
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Adenocarcinoma, Pancreatic Tumors Trial in Saint Louis, Nashville (X-82, Everolimus)

Terminated
Has Results
  • Adenocarcinoma
  • Pancreatic Neoplasms
  • Saint Louis, Missouri
  • +1 more
Jun 15, 2021

Neurofibromatosis Type 2, Neuroma, Acoustic Trial in Los Angeles (RAD001, everolimus)

Active, not recruiting
  • Neurofibromatosis Type 2
  • Neuroma, Acoustic
  • RAD001, everolimus
  • Los Angeles, California
    University of California Los Angeles
Mar 2, 2022

Pancreatic Neuroendocrine Tumors Trial in Beijing, Shanghai, Guangzhou (everolimus)

Active, not recruiting
  • Pancreatic Neuroendocrine Tumors
  • Beijing, Beijing, China
  • +3 more
Sep 27, 2021

Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine Tumors Trial in Atlanta (Lenalidomide, Everolimus)

Completed
Has Results
  • Solid Organ Malignancies
  • +2 more
  • Atlanta, Georgia
  • +1 more
Nov 19, 2021